Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1960 Jan 1;111(1):77-91.
doi: 10.1084/jem.111.1.77.

Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents

Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents

P G KLEIN. J Exp Med. .

Abstract

The interaction of sensitized sheep crythrocytes (EA) with guinea pig complement inactivated by treatment with hydrazine or ether has been studied. In both cases EA is converted into EAC'1. The hemolytic reactivity of this complex with respect to a complement reagent that contains C'4, C'2, and C'3 (R1) decays rapidly in the presence of hydrazine-treated complement (R4) or decomplemented guinea pig serum, but not in the presence of ether-treated guinea pig serum or of saline. The rate of decay of EAC'1 is dependent on the temperature, the reaction volume, and the amount of the inactivating reagent. The capacity of R4 and of decomplemented serum to inactivate EAC'1 can be markedly reduced by treatment with ether. The essential conditions for obtaining an optimally reactive EAC'1 consist in exposing EA to ether-treated guinea pig serum in the cold. This procedure yields a highly reactive EAC'1, even when the cells are sensitized with suboptimal amounts of amboceptor.

PubMed Disclaimer

References

    1. J Exp Med. 1948 Oct 1;88(4):427-44 - PubMed
    1. J Immunol. 1954 Dec;73(6):443-54 - PubMed
    1. J Exp Med. 1960 Jan 1;111:107-17 - PubMed
    1. J Immunol. 1955 Jul;75(1):63-70 - PubMed
    1. J Exp Med. 1942 Jul 1;76(1):93-101 - PubMed

Substances